Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Cryopreserved Saphenous Vein Compared With PTFE Graft for Use as Modified Blalock-Taussig or Central Shunt in Cyanotic Congenital Heart Disease. World J Pediatr Congenit Heart Surg 2018 Sep;9(5):509-512

Date

08/31/2018

Pubmed ID

30157727

DOI

10.1177/2150135118776616

Scopus ID

2-s2.0-85056395170 (requires institutional sign-in at Scopus site)   4 Citations

Abstract

Many infants with congenital heart disease undergo palliative shunt procedures. In our center, cryopreserved saphenous vein and polytetrafluoroethylene (PTFE) are used as grafts to construct these shunts. In this retrospective review, we compare morbidity, mortality, and freedom from reoperation associated with the use of these graft materials. We conducted a retrospective study of 136 consecutive patients who were palliated with shunts between 2006 and 2015. A total of 136 patients were identified, 9 had incomplete data; thus, 127 patients were included: 69 saphenous and 58 PTFE. The cohorts were matched with respect to birth weight, gestational age, age and weight at time of surgery, and underlying cardiac condition. There were 15 (12%) deaths in the study cohort with no intraoperative mortality. Thrombosis was seen in 5.2% (2/38) of the saphenous modified Blalock-Taussig shunt (mBTS) group and 20.6% (14/68) of those with PTFE mBTS. There was no thrombosis in the central shunt group. Freedom from reoperation was 83% in the saphenous vein group and 81% in the PTFE group. There was no difference in overall morbidity or mortality, although thrombosis was significantly less in the saphenous vein group. Cryopreserved saphenous vein is a safe alternative, either as a mBTS or as a central shunt.

Author List

Kaur R, Bhurtel D, Bielefeld MR, Morales JM, Durham LA 3rd

Author

Lucian A. Durham MD, PhD Associate Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Blalock-Taussig Procedure
Cryopreservation
Female
Heart Defects, Congenital
Humans
Incidence
Infant
Infant, Newborn
Polytetrafluoroethylene
Postoperative Complications
Prostheses and Implants
Retrospective Studies
Saphenous Vein
Survival Rate
Time Factors
United States